Kimberly-Clark Corp. (KMB) has been recently undergoing significant stake shifts and price target adjustments by multiple investment firms. Mengis Capital Management, US Bancorp DE, Kingswood Wealth Advisors, Belpointe Asset Management reduced their stakes, while others like Leo Wealth, DAVENPORT & Co, Simplicity Wealth, Grimes & Company, and Elevate Capital Advisors increased their shares. Simultaneously, the price target was lowered by UBS, JPMorgan Chase, Citigroup, and Evercore ISI while Jefferies has initiated the stock with a hold rating.
KMB has demonstrated a commitment to innovation with the advancement of essential care for 24 million women and girls worldwide. They also announced a $2 billion investment to expand US manufacturing and drive innovation.
Kimbely-Clark's Q1 and Q2 2025 Earnings Call highlighted strategic innovations, record sales growth, highest volume growth in 5 years, and margin. However, the company hit a new 12-Month low which resulted in a downward correction in price targets, and despite the announcements of increased dividends, the Q2 earnings were reported to fall below analyst estimates. Nevertheless, the company leads as a key player in the Turbulent Dividend Market.
Kimberly-Clark Corp KMB News Analytics from Tue, 28 Jan 2025 08:00:00 GMT to Sat, 11 Oct 2025 13:50:32 GMT -
Rating -6
- Innovation 4
- Information 8
- Rumor 2
